Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fu...((3.1) (0.05) (14.8) (0.23) ...)

Date:2/9/2009

(3.1) (0.05) (14.8) (0.23) ----- ------ ------ ------ Adjusted net earnings (2) $82.3 $1.29 $69.6 $1.08 ===== ===== ===== ===== Year Ended December 31, ----------------------- 2008 2007 -------------------- ----------------- Per Per Diluted Diluted Amount Share Amount Share ------ ------- ------ ------- GAAP net earnings $194.0 $3.01 $211.3 $3.30 Less: Earnings from discontinued operations, net of tax (k) - - 1.6 0.03 --- --- --- ---- Earnings from continuing operations 194.0 3.01 209.7 3.27 Reconciling items: ----------------- Restructuring expenses (a) 21.4 0.33 17.7 0.29 Environmental remediation (b) 19.0 0.30 - - Royalty buy out (c) 11.7 0.18
'/>"/>

SOURCE Beckman Coulter - IR Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33
Related biology technology :

1. Beckman Coulter to Present at the Bear Stearns Healthcare Conference
2. Beckman Coulter to Present at the UBS Global Life Sciences Conference
3. Beckman Coulter Announces Third Quarter 2007 Earnings to Be Released on Tuesday, October 30, 2007 Before Market Opens
4. Beckman Coulter Declares Quarterly Dividend
5. Beckman Coulter Announces Third Quarter 2007 Results
6. Beckman Coulter to Present at the 19th Annual Piper Jaffray Healthcare Conference
7. Beckman Coulter to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
8. Beckman Coulter to Acquire Exclusive Rights to Break-Through Technologies
9. Beckman Coulter Elects AMN Healthcare Executive to Board of Directors
10. Beckman Coulter to Present at the JPMorgan Healthcare Conference
11. AcroMetrix Signs Development and Supply Agreement With Beckman Coulter Inc. for Molecular Quality Control Standards